畜牧兽医学报 ›› 2005, Vol. 36 ›› Issue (10): 1033-1037.doi:

• 兽医 • 上一篇    下一篇

猪瘟伪狂犬病重组病毒SA215(A)株的构建及生物学特性研究

徐志文;郭万柱;朱 玲;王 印;王晓玉
  

  1. 四川农业大学 动物生物技术中心,雅安 625014
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2005-10-25 发布日期:2005-10-25

Construction and Characterization Analysis of the Recombinant VirusSA215(A) Strain of Pseudorabies Virus-Hog Cholera Virus

XU Zhi-wen;GUO Wan-zhu;ZHU Ling;WANG Yin;WANG Xiao-yu   

  1. Sichuan agricultural University,Yaan 625014,China
  • Received:1900-01-01 Revised:1900-01-01 Online:2005-10-25 Published:2005-10-25

摘要: 采用磷酸钙转染系统,将伪狂犬病三基因缺失疫苗SA215株DNA与PP63LacZE2 DNA共转染Vero细胞,获得SA215(A)1、SA215(A)2和SA215(A)3等12个重组病毒株。以光生物素标记的HCV E2基因为探针进行初步鉴定后,挑选SA215(A)1株作BamHI酶切和southern转印杂交鉴定,结果表明构建是成功的,将其命名为SA215(A)。直接荧光抗体检测、SDS-PAGE电泳和western免疫印迹检测结果表明HCV E2基因在重组病毒内获得表达,产生大小约51 ku的囊膜糖蛋白。对SA215(A)株进行部分生物学特性研究,培养特性观察试验表明该毒株可适应Vero、BHK21和鸡胚成纤维细胞等多种细胞,但对不同细胞系表现有一定的差异。SA215(A)株105 PFU /mL接种21日龄健康仔猪(伪狂犬病和猪瘟检测阴性),接种后28 d用106 PFU的PRV Fa强毒株滴鼻攻毒,42 d用猪瘟SM株血毒1 mL(105 MLD/mL)肌肉注射攻击,结果表明接种猪能抵御2次病毒攻击,表明SA215(A)株具有良好免疫原性,是一株优秀的猪瘟、伪狂犬病二价疫苗候选株。

Abstract: By cotransfection of PRV Fa SA215 DNA and PP63LacZE2 DNA in Vero cells,12 recombinants named SA215(A)1,SA215(A)2…,and SA215(A)12 were obtained with calcium phosphate transfection system. The recombinant strains were determined preliminarily by biotin-labeled probe of HCV E2, then SA215(A)1 strain were identified by BamHI digestion and Southern-blot acid hybridization. The results indicated that the recombinant virus of PRV and HCV named SA215(A) was successful. IFT,SDS-PAGE,electrophoresis and Western-blot all confirmed that HCV E2 gene was expressed in recombinant virus, about 51 ku fragment of envelope glycoprotein E2 were acquired. Research on culture characteristics of SA215(A) strain indicated recombinant virus could be replicated very well on Vero cells, BHK21 cells and so on, but showing variability in culture on different cell lines. 21-day-old SPF pigs were inoculated with SA215(A) strain. After 28 days, the pigs were affected with 106PFU high-dose virulent PRV Fa strain; and 14 days later affected with 105 MLD high-dose virulent HCV SM strain. All of the inoculated pigs were protected. The results indicated SA215(A) was high efficacy.